🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In the Netherlands a 2 center investigator-driven phase I/II clinical trial...
Status
Completed
Location
ERasmus Medical Center
Start Date
2010-06
Trial ID
NCT01582516
Treatments Being Tested
This phase I/II trial studies the side effects of panobinostat nanoparticle...
Status
Completed
Location
University of California, San Francisco
Start Date
2018-05-22
Trial ID
NCT03566199
Treatments Being Tested
This is a phase 1 study of an anti-CD40 monoclonal antibody (2141-V11) in c...
Status
Recruiting
Location
Duke University Medical Center
Start Date
2021-07-09
Trial ID
NCT04547777
Background: * Parkinson s disease (PD) is a progressive neurodegenerative ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2009-06-02
Trial ID
NCT00921128
Treatments Being Tested
This is a phase 2 study of lerapolturev, an oncolytic polio/rhinovirus reco...
Status
Completed
Location
UCSF Neurological Surgery
Start Date
2017-06-01
Trial ID
NCT02986178
Treatments Being Tested
IL13-PE38QQR is an oncology drug product consisting of IL13 (interleukin-13...
Status
Completed
Location
University of California San Francisco
Start Date
2001-06
Trial ID
NCT00024557
Treatments Being Tested
The purpose of this research study is to determine the safety and efficacy ...
Status
Recruiting
Location
Duke University Medical Center
Start Date
2023-09-06
Trial ID
NCT05734560
This is an open-label, single-arm, non-randomized, intermediate-sized expan...
Status
No Longer Available
Location
Duke University Medical Center
Start Date
TBD
Trial ID
NCT04599647
Treatments Being Tested
This study will use an experimental method of delivering the enzyme glucoce...
Status
Completed
Location
National Institute of Neurological Disorders and Stroke (NINDS)
Start Date
2005-10-22
Trial ID
NCT00244582
This Phase 2 single arm trial in patients with rGBM will characterize the e...
Status
Completed
Location
University of California San Francisco
Start Date
2020-10-21
Trial ID
NCT04479241
Treatments Being Tested